DATATRAK International, Inc. (DTRK: OTCQX U.S.) | DATATRAK

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DATATRAK International, Inc. (DTRK: OTCQX U.S.) | DATATRAK International, Inc. Reports First Quarter Results of 2014 DATATRAK International, Inc. Reports First Quarter Results of 2014

DATATRAK International, Inc. Reports First Quarter Results of 2014

-- Continued growth in Revenue and Backlog

-- All Q1 2014 Clients Purchase Multiple Products

PR Newswire

CLEVELAND , May 14, 2014 /PRNewswire/ --  D ATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical ® technologies and delivering related services for the clinical trials industry, today announced its operating results for the first quarter of 2014.

"The benefits of our unified eClinical ® platform are resonating with clients, who realize additional time and cost savings when using multiple products.  The first quarter confirms the value of our unified platform with every client requesting two or more products," said Laurence P. Birch , Chairman and CEO, D ATATRAK .

"In fact, 50% of Q1 2014 contracts include 3 or more products ," continued Birch. "Due to the growth in demand for our products and services, we are funding pivotal investments in sales and marketing capabilities.  These investments are self-funding, due to the high gross profit margin D ATATRAK maintains as a direct result of our unified architecture."

Powered by the D ATATRAK ONE ® unified platform, clients are realizing the benefits made possible by a unified experience.  Eliminating the need to migrate data and implementing mid-study changes while supporting continued work in the trial are among the benefits that deliver greater efficiency to our clients.

"As the industry seeks solutions to optimize their investment in clinical trials, they are realizing our unified experience and unparalleled customer care deliver on that promise better than anyone else," Birch concluded.

The D ATATRAK ONE ® platform delivers the unified experience and is the technical infrastructure that powers all D ATATRAK products, which can be used in any combination.  The inherent strength of D ATATRAK products is the intrinsic connectivity to the platform, providing a single data source, a single sign-on and a single user-friendly interface, greatly reducing clinical trial complexities. 

Highlights include:

  • First quarter 2014 revenues increased to $2.7 million from $2.6 million from the same period in 2013, an increase of 4% year-over-year
  • Gross Profit Margin for the quarter remained stable at 81%
  • Backlog at March 31, 2014 totaled $21.3 million
  • D ATATRAK leadership featured in 5 speaking engagements at 3 Trade Shows, including DIA Euromeeting, 17 th Annual Workshop in Japan for CDM, and ACRP Global Conference & Exhibition
  • D ATATRAK Chairman and CEO, Laurence P. Birch , appointed to the Metropolitan Chicago YMCA Board of Managers – recognized for outstanding leadership
  • D ATATRAK extends leadership to preclinical trials through a partnership with Texas A&M Institute for Preclinical Studies
  • D ATATRAK teams with Clinverse to drive costs out of clinical trials

Financial Highlights:
Revenue increased by 4% to $2.67 million in the first quarter of 2014 compared to $2.58 million in the first quarter of 2013.  While direct costs increased slightly in order to service a higher level of revenue than the prior year, the gross profit margin remained stable at 81% for both the three months ended March 31, 2014 and 2013. SG&A expenses decreased 1% for the three months ended March 31, 2014 . As a result, the Company's loss from operations for the three months ended March 31, 2014 was $(287,000) compared to $(389,000) for the corresponding period in the prior year.

D ATATRAK 's backlog at March 31, 2014 was $21.3 million compared to a backlog of $20.9 million at December 31, 2013 . Backlog consists of future value from authorization letters to commence services, statements of work, technology and services agreements, change orders and other customer contracts, billed and unbilled. The improvement in backlog from December 31, 2013 to March 31, 2014 was due to new contract sales, change orders and contract amendments. 

Join D ATATRAK Thought Leaders:

Tweet: 100% of #DATATRAK Q1 2014 Contracts for Multiple Products, activating time and cost savings http://bit.ly/1jEG7th

About D ATATRAK International, Inc.
D ATATRAK International is a worldwide technology and services company delivering unified eClinical ® solutions and related services for the clinical trials industry. D ATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via D ATATRAK 's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The D ATATRAK ONE ® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. D ATATRAK has offices located in Cleveland, Ohio ; Bryan, Texas ; and Cary (RTP), North Carolina . D ATATRAK has established a UK entity to support our burgeoning European sales activities; D ATATRAK Technologies Limited is a private limited company registered in England and Wales under number 8870946, registered office: One New Change, London , EC4M 9AF, England . For more information, visit http://www.datatrak.com .

All contracts are subject to possible delays or cancellation or can change in scope in a positive or negative direction. Therefore, current backlog is not necessarily indicative of the Company's future quarterly or annual revenue. Historically, backlog has been a poor predictor of the Company's short-term revenue.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 14, 2014 announcing its results for the full-year period ending December 31, 2013 . The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

 

D ATATRAK International, Inc. and Subsidiaries

Condensed Consolidated Balance Sheet Data

(Unaudited)



March 31, 2014

December 31, 2013

Cash and cash equivalents

$2,610,168

$3,305,852

Accounts receivable, net

1,299,128

1,084,377

Property & equipment, net

254,411

190,799

Deferred tax assets

—

—

Other

387,138

461,196

   Total assets

$4,550,845

$5,042,224




Accounts payable and other current liabilities

$1,194,028

$1,855,061

Deferred revenue

4,500,827

4,425,167

Other long-term liabilities

32,165

29,775

Shareholders'  deficit

(1,176,175)

(1,267,779)

   Total liabilities and shareholders' deficit

$4,550.845

$5,042.224





D ATATRAK International, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)



For the 3 Months Ended March 31,


2014

2013

Revenue

$2,674,488

$2,582,477

Direct costs

512,604

482,652

   Gross profit

2,161,884

2,099,825




Selling, general and administrative expenses

2,434,615

2,467,012

Depreciation and amortization

14,730

21,930

   Loss from operations

(287,461)

(389,117)




Interest income

349

93

Interest expense

(2,922)

(3,150)

Other income

—

750,000

   Net (loss) income

$(290,034)

$   357,826

     Net (loss) income per share:



          Net (loss) income per share, basic

$     (0.21)

$        0.28

          Weighted-average shares outstanding, basic

1,411,186

1,300,716

         

          Net (loss) income per share, diluted

$     (0.21)

$       0.25

          Weighted-average shares outstanding, diluted

1,411,186

1,443,670





 

SOURCE DATATRAK International, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 210

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 187

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 169

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 302

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Kipu Health Strengthens Behavioral Health with Hatch Compliance Deal

Updated Category News Views 184

Kipu Health Expands Its Portfolio with a Strategic Acquisition Kipu Health is making a significant advancement in the behavioral health sector by acquiring Hatch Compliance. This merger brings in cutting-edge compliance management systems specifically designed for behavioral health organizations. Boosting Operational Efficiency for Behavioral Health Organizations As a...

Continue Reading
Exploring the Future of Autonomous Economy with Lav and Magma

Updated Category News Views 245

Understanding the Autonomous Economy Lava Network and Magma Devs, in collaboration with Google Cloud, are set to delve into the transformative concept of the autonomous economy. This ambitious initiative aims to showcase how artificial intelligence (AI) agents and stablecoins are revolutionizing digital commerce. The exciting event will bring together industry leaders to...

Continue Reading
Micross Expands with AEMtec Acquisition: European Growth

Updated Category News Views 68

Micross Advances into Europe with AEMtec Acquisition Here's the scoop: Micross Components, a heavyweight in microelectronics, just sealed a deal to acquire AEMtec GmbH. This acquisition isn't just peanuts—it's a big leap forward for Micross, broadening its European presence and bolstering its advanced packaging and optoelectronics game. You'd think these folks mean...

Continue Reading
Innovative Vanpool Program Revolutionizes Student Transportation

Updated Category News Views 128

Transforming Student Transportation with Vanpool Systems Augusta County Public Schools has taken a significant step in improving student transportation through an innovative vanpool program. Collaborating with Secure Solar Futures, this program focuses on utilizing plug-in electric vans, greatly enhancing the transportation experience for students. How the Vanpool Program...

Continue Reading
Understanding Market Sentiments Surrounding XPO Logistics

Updated Category News Views 131

XPO's Short Interest Overview XPO's short percent of float has declined by 10.67% since the last report, with a current tally of 5.26 million shares sold short. This accounts for 5.19% of the overall shares available for trading. On average, it would take approximately 3.87 days for traders to cover their short positions based on the recent trading volumes. Importance of...

Continue Reading